Atlas Trials

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Clinical trial NCT03631004 · COMPLETED

Trial details

NCT number
NCT03631004
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Postoperative NauseaPostoperative Nausea and Vomiting
Start date
2018-10-01
Primary completion
2021-02-10
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.